{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:11:41Z","timestamp":1787008301161,"version":"build-2736575974"},"reference-count":41,"publisher":"China Science Publishing & Media Ltd.","issue":"4","license":[{"start":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T00:00:00Z","timestamp":1551312000000},"content-version":"vor","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010032","name":"Shanghai Municipal Commission of Health and Family Planning","doi-asserted-by":"publisher","award":["20164Y0255"],"award-info":[{"award-number":["20164Y0255"]}],"id":[{"id":"10.13039\/501100010032","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1093\/abbs\/gmz015","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T07:18:59Z","timestamp":1548919139000},"page":"375-385","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":32,"title":["TCF7L1 indicates prognosis and promotes proliferation through activation of Keap1\/NRF2 in gastric cancer"],"prefix":"10.3724","volume":"51","author":[{"given":"Beili","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jugang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yantao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2019,2,28]]},"reference":[{"key":"null","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"Ferlay J","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 2015, 136: E359-E386.","journal-title":"Int J Cancer"},{"key":"null","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"Torre LA","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin, 2015, 65: 87-108.","journal-title":"CA Cancer J Clin"},{"key":"null","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.3748\/wjg.v20.i7.1635","volume":"20","author":"Orditura M","year":"2014","unstructured":"Orditura M, Galizia G, Sforza V, Gambardella V, Fabozzi A, Laterza MM, Andreozzi F. Treatment of gastric cancer. World J Gastroenterol, 2014, 20: 1635-1649.","journal-title":"World J Gastroenterol"},{"key":"null","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4103\/1477-3163.146506","volume":"13","author":"Carcas LP","year":"2014","unstructured":"Carcas LP. Gastric cancer review. J Carcinog, 2014, 13:","journal-title":"J Carcinog"},{"key":"null","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nrgastro.2014.143","volume":"11","author":"McLean MH","year":"2014","unstructured":"McLean MH, El-Omar EM. Genetics of gastric cancer. Nat Rev Gastroenterol Hepatol, 2014, 11: 664-674.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"null","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrc3597","volume":"13","author":"Beck B","year":"2013","unstructured":"Beck B, Blanpain C. Unravelling cancer stem cell potential. Nat Rev Cancer, 2013, 13: 727-738.","journal-title":"Nat Rev Cancer"},{"key":"null","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/ng.127","volume":"40","author":"Ben-Porath I","year":"2008","unstructured":"Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, Weinberg RA. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet, 2008, 40: 499-507.","journal-title":"Nat Genet"},{"key":"null","volume":"6","author":"Ku AT","year":"2017","unstructured":"Ku AT, Shaver TM, Rao AS, Howard JM, Rodriguez CN, Miao Q, Garcia G. TCF7L1 promotes skin tumorigenesis independently of beta-catenin through induction of LCN2. Elife, 2017, 6:","journal-title":"Elife"},{"key":"null","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.celrep.2013.06.001","volume":"4","author":"Shy BR","year":"2013","unstructured":"Shy BR, Wu CI, Khramtsova GF, Zhang JY, Olopade OI, Goss KH, Merrill BJ. Regulation of Tcf7l1 DNA binding and protein stability as principal mechanisms of Wnt\/beta-catenin signaling. Cell Rep, 2013, 4: 1-9.","journal-title":"Cell Rep"},{"key":"null","doi-asserted-by":"crossref","first-page":"356","DOI":"10.15252\/embj.201592116","volume":"35","author":"Morrison G","year":"2016","unstructured":"Morrison G, Scognamiglio R, Trumpp A, Smith A. Convergence of cMyc and beta-catenin on Tcf7l1 enables endoderm specification. EMBO J, 2016, 35: 356-368.","journal-title":"EMBO J"},{"key":"null","doi-asserted-by":"crossref","first-page":"28299","DOI":"10.1038\/srep28299","volume":"6","author":"Murphy M","year":"2016","unstructured":"Murphy M, Chatterjee SS, Jain S, Katari M, DasGupta R. TCF7L1 modulates colorectal cancer growth by inhibiting expression of the tumor-suppressor gene EPHB3. Sci Rep, 2016, 6:","journal-title":"Sci Rep"},{"key":"null","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.1158\/0008-5472.CAN-12-0119","volume":"72","author":"Slyper M","year":"2012","unstructured":"Slyper M, Shahar A, Bar-Ziv A, Granit RZ, Hamburger T, Maly B, Peretz T. Control of breast cancer growth and initiation by the stem cell-associated transcription factor TCF3. Cancer Res, 2012, 72: 5613-5624.","journal-title":"Cancer Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.3892\/ijo.2016.3480","volume":"48","author":"Wu C","year":"2016","unstructured":"Wu C, Zhuang Y, Jiang S, Liu S, Zhou J, Wu J, Teng Y. Interaction between Wnt\/beta-catenin pathway and microRNAs regulates epithelial-mesenchymal transition in gastric cancer (Review). Int J Oncol, 2016, 48: 2236-2246.","journal-title":"Int J Oncol"},{"key":"null","doi-asserted-by":"crossref","first-page":"35579","DOI":"10.18632\/oncotarget.5758","volume":"6","author":"Song X","year":"2015","unstructured":"Song X, Xin N, Wang W, Zhao C. Wnt\/beta-catenin, an oncogenic pathway targeted by H. pylori in gastric carcinogenesis. Oncotarget, 2015, 6: 35579-35588.","journal-title":"Oncotarget"},{"key":"null","doi-asserted-by":"crossref","first-page":"84","DOI":"10.5493\/wjem.v5.i2.84","volume":"5","author":"Chiurillo MA","year":"2015","unstructured":"Chiurillo MA. Role of the Wnt\/beta-catenin pathway in gastric cancer: an in-depth literature review. World J Exp Med, 2015, 5: 84-102.","journal-title":"World J Exp Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.cell.2006.01.040","volume":"124","author":"Moffat J","year":"2006","unstructured":"Moffat J, Grueneberg DA, Yang X, Kim SY, Kloepfer AM, Hinkle G, Piqani B. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell, 2006, 124: 1283-1298.","journal-title":"Cell"},{"key":"null","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2174\/1566524016666160316154150","volume":"16","author":"Zhang B","year":"2016","unstructured":"Zhang B, Xu J, Li C, Shi S, Ji S, Xu W, Liu J. MBD1 is an epigenetic regulator of KEAP1 in pancreatic cancer. Curr Mol Med, 2016, 16: 404-411.","journal-title":"Curr Mol Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.bbrc.2017.04.123","volume":"487","author":"Eshelman MA","year":"2017","unstructured":"Eshelman MA, Shah M, Raup-Konsavage WM, Rennoll SA, Yochum GS. TCF7L1 recruits CtBP and HDAC1 to repress DICKKOPF4 gene expression in human colorectal cancer cells. Biochem Biophys Res Commun, 2017, 487: 716-722.","journal-title":"Biochem Biophys Res Commun"},{"key":"null","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3324\/haematol.2014.104695","volume":"99","author":"Ma H","year":"2014","unstructured":"Ma H, Mallampati S, Lu Y, Sun B, Wang E, Leng X, Gong Y. The Sox4\/Tcf7l1 axis promotes progression of BCR-ABL-positive acute lymphoblastic leukemia. Haematologica, 2014, 99: 1591-1598.","journal-title":"Haematologica"},{"key":"null","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrc2468","volume":"8","author":"Denko NC","year":"2008","unstructured":"Denko NC. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer, 2008, 8: 705-713.","journal-title":"Nat Rev Cancer"},{"key":"null","author":"Poff A","year":"2017","unstructured":"Poff A, Koutnik AP, Egan KM, Sahebjam S, D\u2019Agostino D, Kumar NB. Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma. Semin Cancer Biol, 2017,","journal-title":"Semin Cancer Biol"},{"key":"null","first-page":"556","volume":"2017","author":"Danhier P","year":"1858","unstructured":"Danhier P, Banski P, Payen VL, Grasso D, Ippolito L, Sonveaux P, Porporato PE. Cancer metabolism in space and time: beyond the Warburg effect. Biochim Biophys Acta, 1858, 2017: 556-572.","journal-title":"Biochim Biophys Acta"},{"key":"null","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.1038\/cddis.2011.123","volume":"3","author":"Munoz-Pinedo C","year":"2012","unstructured":"Munoz-Pinedo C, El Mjiyad N, Ricci JE. Cancer metabolism: current perspectives and future directions. Cell Death Dis, 2012, 3:","journal-title":"Cell Death Dis"},{"key":"null","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.semcancer.2017.01.005","volume":"43","author":"Schwartz L","year":"2017","unstructured":"Schwartz L, Seyfried T, Alfarouk KO, Da Veiga Moreira J, Fais S. Out of Warburg effect: an effective cancer treatment targeting the tumor specific metabolism and dysregulated pH. Semin Cancer Biol, 2017, 43: 134-138.","journal-title":"Semin Cancer Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13046-018-0673-y","volume":"37","author":"Fan Q","year":"2018","unstructured":"Fan Q, Yang L, Zhang X, Ma Y, Li Y, Dong L, Zong Z. Autophagy promotes metastasis and glycolysis by upregulating MCT1 expression and Wnt\/beta-catenin signaling pathway activation in hepatocellular carcinoma cells. J Exp Clin Cancer Res, 2018, 37:","journal-title":"J Exp Clin Cancer Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.15252\/embj.201488598","volume":"33","author":"Pate KT","year":"2014","unstructured":"Pate KT, Stringari C, Sprowl-Tanio S, Wang K, TeSlaa T, Hoverter NP, McQuade MM. Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer. EMBO J, 2014, 33: 1454-1473.","journal-title":"EMBO J"},{"key":"null","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrc3278","volume":"12","author":"Sporn MB","year":"2012","unstructured":"Sporn MB, Liby KT. NRF2 and cancer: the good, the bad and the importance of context. Nat Rev Cancer, 2012, 12: 564-571.","journal-title":"Nat Rev Cancer"},{"key":"null","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1158\/0008-5472.CAN-16-2204","volume":"77","author":"Lu K","year":"2017","unstructured":"Lu K, Alcivar AL, Ma J, Foo TK, Zywea S, Mahdi A, Huo Y. NRF2 induction supporting breast cancer cell survival is enabled by oxidative stress-induced DPP3-KEAP1 interaction. Cancer Res, 2017, 77: 2881-2892.","journal-title":"Cancer Res"},{"key":"null","first-page":"5642","volume":"8","author":"Liew PL","year":"2015","unstructured":"Liew PL, Hsu CS, Liu WM, Lee YC, Lee YC, Chen CL. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma. Int J Clin Exp Pathol, 2015, 8: 5642-5649.","journal-title":"Int J Clin Exp Pathol"},{"key":"null","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1476-4598-10-37","volume":"10","author":"Lister A","year":"2011","unstructured":"Lister A, Nedjadi T, Kitteringham NR, Campbell F, Costello E, Lloyd B, Copple IM. Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy. Mol Cancer, 2011, 10:","journal-title":"Mol Cancer"},{"key":"null","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12885-017-3907-z","volume":"18","author":"Namani A","year":"2018","unstructured":"Namani A, Matiur Rahaman M, Chen M, Tang X. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer. BMC Cancer, 2018, 18:","journal-title":"BMC Cancer"},{"key":"null","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ccr.2012.05.016","volume":"22","author":"Mitsuishi Y","year":"2012","unstructured":"Mitsuishi Y, Taguchi K, Kawatani Y, Shibata T, Nukiwa T, Aburatani H, Yamamoto M. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell, 2012, 22: 66-79.","journal-title":"Cancer Cell"},{"key":"null","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.biocel.2017.12.016","volume":"95","author":"Zhang HS","year":"2018","unstructured":"Zhang HS, Du GY, Zhang ZG, Zhou Z, Sun HL, Yu XY, Shi YT. NRF2 facilitates breast cancer cell growth via HIF1a-mediated metabolic reprogramming. Int J Biochem Cell Biol, 2018, 95: 85-92.","journal-title":"Int J Biochem Cell Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1089\/ars.2014.6040","volume":"22","author":"Rada P","year":"2015","unstructured":"Rada P, Rojo AI, Offergeld A, Feng GJ, Velasco-Martin JP, Gonzalez-Sancho JM, Valverde AM. WNT-3A regulates an Axin1\/NRF2 complex that regulates antioxidant metabolism in hepatocytes. Antioxid Redox Signal, 2015, 22: 555-571.","journal-title":"Antioxid Redox Signal"},{"key":"null","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/carcin\/bgn095","volume":"29","author":"Wang XJ","year":"2008","unstructured":"Wang XJ, Sun Z, Villeneuve NF, Zhang S, Zhao F, Li Y, Chen W. Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis, 2008, 29: 1235-1243.","journal-title":"Carcinogenesis"},{"key":"null","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1080\/14728222.2017.1389900","volume":"21","author":"Yang W","year":"2017","unstructured":"Yang W, Ma J, Zhou W, Cao B, Zhou X, Yang Z, Zhang H. Molecular mechanisms and theranostic potential of miRNAs in drug resistance of gastric cancer. Expert Opin Ther Targets, 2017, 21: 1063-1075.","journal-title":"Expert Opin Ther Targets"},{"key":"null","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1158\/0008-5472.CAN-07-5003","volume":"68","author":"Ohta T","year":"2008","unstructured":"Ohta T, Iijima K, Miyamoto M, Nakahara I, Tanaka H, Ohtsuji M, Suzuki T. Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res, 2008, 68: 1303-1309.","journal-title":"Cancer Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2559.2012.04178.x","volume":"60","author":"Yoo NJ","year":"2012","unstructured":"Yoo NJ, Kim HR, Kim YR, An CH, Lee SH. Somatic mutations of the KEAP1 gene in common solid cancers. Histopathology, 2012, 60: 943-952.","journal-title":"Histopathology"},{"key":"null","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4161\/epi.23319","volume":"8","author":"Barbano R","year":"2013","unstructured":"Barbano R, Muscarella LA, Pasculli B, Valori VM, Fontana A, Coco M, la Torre A. Aberrant Keap1 methylation in breast cancer and association with clinicopathological features. Epigenetics, 2013, 8: 105-112.","journal-title":"Epigenetics"},{"key":"null","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2407-12-66","volume":"12","author":"Hanada N","year":"2012","unstructured":"Hanada N, Takahata T, Zhou Q, Ye X, Sun R, Itoh J, Ishiguro A. Methylation of the KEAP1 gene promoter region in human colorectal cancer. BMC Cancer, 2012, 12:","journal-title":"BMC Cancer"},{"key":"null","doi-asserted-by":"crossref","first-page":"710","DOI":"10.4161\/epi.6.6.15773","volume":"6","author":"Muscarella LA","year":"2011","unstructured":"Muscarella LA, Parrella P, D\u2019Alessandro V, la Torre A, Barbano R, Fontana A, Tancredi A. Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer. Epigenetics, 2011, 6: 710-719.","journal-title":"Epigenetics"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/2389BF4AFA5F49C79EEF67E4EF72B52D","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmz015","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/2389BF4AFA5F49C79EEF67E4EF72B52D","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T01:31:51Z","timestamp":1662859911000},"score":1,"resource":{"primary":{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmz015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,1]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,2,28]]},"published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/abbs\/gmz015","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2,1]]}}}